Ventripoint Diagnostics Appoints Thomas Brown as Director of Congenital Heart Defect Program
Thenewswire·2025-08-18 12:10
Toronto, Ontario – TheNewswire - August 18, 2025 – Ventripoint Diagnostics Ltd. (“Ventripoint” or the “Corporation”,) (TSXV:VPT; OTC:VPTDF) a leader in AI-powered heart analysis solutions, is pleased to announce the appointment of Thomas Brown, former Vice President of North American Sales at Intelligent Ultrasound, as Director of the Congenital Heart Defect (CHD) Program. Mr. Brown brings more than 20 years of leadership experience in global medical imaging sales, commercialization, and market expansion. ...